SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fabrizio De Benedetti, Rayfel Schneider, Textbook of Pediatric Rheumatology, 2016,

    CrossRef

  2. 2
    Norman T. Ilowite, Ronald M. Laxer, Textbook of Pediatric Rheumatology, 2016,

    CrossRef

  3. 3
    Nico M Wulffraat, A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis, Expert Opinion on Drug Safety, 2015, 14, 12, 1961

    CrossRef

  4. 4
    Sheridan M. Hoy, Canakinumab: A Review of Its Use in the Management of Systemic Juvenile Idiopathic Arthritis, BioDrugs, 2015, 29, 2, 133

    CrossRef

  5. 5
    Andreas Woerner, Annette von Scheven-Gête, Rolando Cimaz, Michaël Hofer, Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations, Expert Review of Clinical Immunology, 2015, 11, 5, 575

    CrossRef

  6. 6
    Angelo Ravelli, Sergio Davì, Francesca Minoia, Alberto Martini, Randy Q. Cron, Macrophage Activation Syndrome, Hematology/Oncology Clinics of North America, 2015, 29, 5, 927

    CrossRef

  7. 7
    Tim Niehues, Optimizing treatment in paediatric rheumatology—lessons from oncology, Nature Reviews Rheumatology, 2015, 11, 8, 493

    CrossRef

  8. 8
    Serena Colafrancesco, Roberta Priori, Guido Valesini, Presentation and diagnosis of adult-onset Still’s disease: the implications of current and emerging markers in overcoming the diagnostic challenge, Expert Review of Clinical Immunology, 2015, 11, 6, 749

    CrossRef

  9. 9
    Mahesh babu Ramamurthy, Daniel Y.T. Goh, Michael Teik Chung Lim, Rare Lung Diseases: Interstitial Lung Diseases and Lung Manifestations of Rheumatological Diseases, The Indian Journal of Pediatrics, 2015, 82, 10, 956

    CrossRef

  10. 10
    Francesca Minoia, Sergio Davì, AnnaCarin Horne, Erkan Demirkaya, Francesca Bovis, Caifeng Li, Kai Lehmberg, Sheila Weitzman, Antonella Insalaco, Carine Wouters, Susan Shenoi, Graciela Espada, Seza Ozen, Jordi Anton, Raju Khubchandani, Ricardo Russo, Priyankar Pal, Ozgur Kasapcopur, Paivi Miettunen, Despoina Maritsi, Rosa Merino, Bita Shakoory, Maria Alessio, Vyacheslav Chasnyk, Helga Sanner, Yi-Jin Gao, Zeng Huasong, Toshiyuki Kitoh, Tadej Avcin, Michel Fischbach, Michael Frosch, Alexei Grom, Adam Huber, Marija Jelusic, Sujata Sawhney, Yosef Uziel, Nicolino Ruperto, Alberto Martini, Randy Q. Cron, Angelo Ravelli, Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients, Arthritis & Rheumatology, 2014, 66, 11
  11. 11
    Sebastiaan J. Vastert, Wilco Jager, Bo Jan Noordman, Dirk Holzinger, Wietse Kuis, Berent J. Prakken, Nico M. Wulffraat, Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study, Arthritis & Rheumatology, 2014, 66, 4
  12. 12
    Peter A. Nigrovic, Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?, Arthritis & Rheumatology, 2014, 66, 6
  13. 13
    Matthew L Stoll, Randy Q Cron, Treatment of juvenile idiopathic arthritis: a revolution in care, Pediatric Rheumatology, 2014, 12, 1, 13

    CrossRef

  14. 14
    James E. Frampton, Tocilizumab: A Review of Its Use in the Treatment of Juvenile Idiopathic Arthritis, Pediatric Drugs, 2013, 15, 6, 515

    CrossRef